ResultsIQ

ResultsIQ › Latest results › Viyash Scientific Limited

Viyash Scientific Limited Q1 FY27 earnings call summary

NSE: VIYASH · BSE: 512529

Earnings call of 12 Aug 2026, summarised by AI from the filing.

EBITDA margins around 20%-22% for FY27, as indicated earlier.

Key takeaways

  1. Guidance EBITDA margins around 20%-22% for FY27, as indicated earlier.
  2. Balance sheet Net debt fell to ₹86 cr; net debt to EBITDA 0.1x versus 0.24x last quarter.
  3. Growth driver US business grew 60% on backward integration and new launches.
  4. Risk API revenue flat quarter-on-quarter due to raw material price volatility and customer wait-and-watch.

Original filing on BSE

Viyash Scientific Limited Q1 FY27 results

As filed: Revenue ₹946 cr, EBITDA ₹178 cr, PAT ₹79.3 cr, EBITDA margin 18.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹946 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹920 cr, EBITDA ₹184 cr, PAT ₹66.4 cr, EBITDA margin 20.0%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹920 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.0% in 30 days (Nifty 500: +3.0%).
  • Q3 FY26: Revenue ₹858 cr, EBITDA ₹176 cr, PAT ₹48.5 cr, EBITDA margin 20.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹858 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.7% in 30 days (Nifty 500: +2.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Viyash Scientific Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.